Antibiotic resistance of obligate anaerobes isolated from patients with coloproctological diseases

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

BACKGROUND: Anaerobic infections are life-threatening, often severe, and dangerous for patients with comorbidities. However, in the routine practice of microbiological laboratories, anaerobes are usually not cultured or identified, and the susceptibility of obligate anaerobes to antibiotics is rarely determined. However, antibiotic resistance has increased worldwide, including among anaerobic bacteria.

AIM: The aim of the study was to evaluate the susceptibility of etiologically significant species of obligate anaerobic bacteria isolated from patients with coloproctological diseases from different regions of the Russian Federation.

MATERIALS AND METHODS: The multicenter, prospective, uncontrolled study included etiologically significant obligate anaerobes isolated from patients with coloproctological diseases in 65 regions of the Russian Federation. Subsequent evaluation of antibiotic susceptibility was performed in accordance with the regulatory documents used in the Russian Federation.

RESULTS: As a result of the study, 1,200 strains of obligate anaerobes of 123 species were collected. The analysis included the results of susceptibility testing of 430 anaerobic strains causing proctological infections, including Bacteroides (n =202), Parabacteroides (n =22), Phocaeicola vulgatus (n =104), Prevotella (n =11), Clostridium perfringens (n =91). Resistance to metronidazole, clindamycin, meropenem and vancomycin was detected in 77.3%, 72.7%, 62.5% and 8.79% of the strains, respectively.

CONCLUSION: Monitoring for antibiotic resistance in obligate anaerobes that pose a threat of spreading antibiotic-resistant strains helps reduce the spread of resistance and personalizes antimicrobial therapy and prevention protocols for patients, reducing treatment costs and hospital stay time by quickly switching from empiric to etiotropic therapy.

全文:

受限制的访问

作者简介

Alina Melkumyan

State Scientific Centre of Coloproctology named after A.N. Ryzhih; Russian Medical Academy of Continuous Professional Education

编辑信件的主要联系方式.
Email: alinamelkumyan@yandex.ru
ORCID iD: 0000-0002-5494-415X
SPIN 代码: 2313-8930

MD, Cand. Sci. (Medicine)

俄罗斯联邦, 2 Salyama Adilya street, 123423 Moscow; Moscow

Sergey Achkasov

State Scientific Centre of Coloproctology named after A.N. Ryzhih; Russian Medical Academy of Continuous Professional Education

Email: info@gnck.ru
ORCID iD: 0000-0001-9294-5447
SPIN 代码: 5467-1062

MD, Dr. Sci. (Medicine), Professor, corresponding member of the Russian Academy of Sciences

俄罗斯联邦, 2 Salyama Adilya street, 123423 Moscow; Moscow

Anastasia Shafikova

State Scientific Centre of Coloproctology named after A.N. Ryzhih

Email: shafikova_aa@gnck.ru
ORCID iD: 0009-0000-8669-1014
SPIN 代码: 7709-2996
俄罗斯联邦, 2 Salyama Adilya street, 123423 Moscow

Daria Chistyakova

State Scientific Centre of Coloproctology named after A.N. Ryzhih

Email: chistyakova_da@gnck.ru
ORCID iD: 0000-0002-2486-081X
SPIN 代码: 7628-3590
俄罗斯联邦, 2 Salyama Adilya street, 123423 Moscow

Mikhail Spivak

State Scientific Centre of Coloproctology named after A.N. Ryzhih

Email: spivak_mv@gnck.ru
ORCID iD: 0009-0009-8798-5917
SPIN 代码: 8907-4606
俄罗斯联邦, 2 Salyama Adilya street, 123423 Moscow

Olga Orlova

City Clinical Hospital No. 67 named after L.A. Vorohobov

Email: o.e.orlova@yandex.ru
ORCID iD: 0000-0001-7210-1116
SPIN 代码: 6817-3251

Cand. Sci. (Biology)

俄罗斯联邦, Moscow

Svetlana Gordeeva

Clinical Infectious Diseases Hospital named after S.P. Botkin

Email: svetalgor@mail.ru
ORCID iD: 0000-0003-0370-9624
SPIN 代码: 3832-9109
俄罗斯联邦, Saint Petersburg

Zhanna Khamtsova

Center for Specialized Types of Medical Care named after. V.P. Avaev

Email: hamtsova@yandex.ru
ORCID iD: 0000-0002-7642-098X
SPIN 代码: 2469-7024
俄罗斯联邦, Tver

Antonina Vetokhina

Irkutsk Order of the Badge of Honor Regional Clinical Hospital

Email: an.vetohina@yandex.ru
ORCID iD: 0009-0009-1944-0253
SPIN 代码: 3343-9667
俄罗斯联邦, Irkutsk

参考

  1. Brown SR, Fearnhead NS, Faiz OD, et al. The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease. Colorectal Dis. 2018;20 Suppl 8:3–117. doi: 10.1111/codi.14448
  2. Brusina EB, Rychagov IP. Epidemiology of nosocomial purulent-septic infections in surgery. Moscow : Nauka; 2006. 168 p. EDN: SJHPUP
  3. Feldblyum IV, Zakharova YuA. Nosocomial infections: issues of terminology and modern classification. Epidemiology and Vaccinal Prevention. 2009;1:19–24. EDN: KHOITV
  4. Zueva LP, Yafaev RKh. Epidemiology: textbook. St. Petersburg: Foliot, 2005. 752 p.
  5. Malashenko AA, Aslanov BI, Nechaev VV. Active Epidemiological Surveillance: the Key for Effective Infection Prevention in Pediatric Surgery. Epidemiology and Vaccinal Prevention. 2018;17(6):76–80. doi: 10.31631/2073-3046-2018-17-76-80
  6. Martin D, Hübner M, Moulin E, et al. Timing, diagnosis, and treatment of surgical site infections after colonic surgery: prospective surveillance of 1263 patients. J Hosp Infect. 2018;100(4):393–399. doi: 10.1016/j.jhin.2018.09.011
  7. K B, R S, J S, et al. Surgical Site Infections in Gastrointestinal Surgeries: Estimation of Prevalence, Risk Factors and Bacteriological Profile. Cureus. 2024;16(6):e62589. doi: 10.7759/cureus.62589
  8. Nagy E, Boyanova L, Justesen US, ESCMID Study Group of Anaerobic Infections. How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories. Clin Microbiol Infect. 2018;24(11):1139–1148. doi: 10.1016/j.cmi.2018.02.008
  9. Schuetz AN. Antimicrobial resistance and susceptibility testing of anaerobic bacteria. Clin Infect Dis. 2014;59(5):698–705. doi: 10.1093/cid/ciu395
  10. Nagy E, Urbán E, Nord CE, ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect. 2011;17(3):371–379. doi: 10.1111/j.1469-0691.2010.03256.x
  11. Wright GD. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat Rev Microbiol. 2007;5(3):175–186. doi: 10.1038/nrmicro1614
  12. Salyers AA, Gupta A, Wang Y. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol. 2004;12(9):412–416. doi: 10.1016/j.tim.2004.07.004
  13. Cooley L, Teng J. Anaerobic resistance: should we be worried? Curr Opin Infect Dis. 2019;32(6):523–530. doi: 10.1097/QCO.0000000000000595
  14. Russian recommendations. Determination of the sensitivity of microorganisms to antimicrobial drugs. Version 2024-02. MAKMAKH, SSMU: Smolensk; 2024. 192 p. (In Russ.)
  15. Kuzmenkov AY, Trushin IV, Vinogradova AG, et al. AMRmap: An Interactive Web Platform for Analysis of Antimicrobial Resistance Surveillance Data in Russia. Front Microbiol. 2021;12:620002. doi: 10.3389/fmicb.2021.620002
  16. Vinogradova AG, Kuzmenkov AYu. Application of AMRmap: «from the general to the specific» approach by the example of Klebsiella pneumoniae. Clinical Microbiology and Antimicrobial Chemotherapy. 2019;21(2):181–186. doi: 10.36488/cmac.2019.2.181-186

补充文件

附件文件
动作
1. JATS XML
2. Fig. 1. Distribution of patients by place of residence.

下载 (381KB)
3. Fig. 2. The number of patients, in accordance with the diagnoses according to ICD-10, from whom strains of the collection of obligate anaerobic microorganisms were obtained.

下载 (289KB)
4. Fig. 3. Generic composition of the collection of obligate anaerobic microorganisms.

下载 (239KB)

版权所有 © Melkumyan A.R., Achkasov S.I., Shafikova A.A., Chistyakova D.A., Spivak M.V., Orlova O.E., Gordeeva S.A., Khamtsova Z.V., Vetokhina A.V., 2024

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ:  ПИ № ФС 77 - 86785 от 05.02.2024 (ранее — ПИ № ФС 77 - 59057 от 22.08.2014).